Centaurus Financial Inc. Sells 1,102 Shares of McKesson Corporation $MCK

Centaurus Financial Inc. cut its stake in shares of McKesson Corporation (NYSE:MCK) by 20.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,305 shares of the company’s stock after selling 1,102 shares during the period. Centaurus Financial Inc.’s holdings in McKesson were worth $3,725,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of MCK. Bull Harbor Capital LLC acquired a new position in shares of McKesson during the first quarter worth $341,000. Strategic Investment Advisors MI raised its position in McKesson by 40.3% during the 1st quarter. Strategic Investment Advisors MI now owns 1,181 shares of the company’s stock worth $1,022,000 after purchasing an additional 339 shares during the last quarter. Smith Group Asset Management LLC raised its position in McKesson by 7.9% during the 1st quarter. Smith Group Asset Management LLC now owns 62,597 shares of the company’s stock worth $54,169,000 after purchasing an additional 4,564 shares during the last quarter. Sunbelt Securities Inc. lifted its holdings in McKesson by 409.9% during the 1st quarter. Sunbelt Securities Inc. now owns 2,779 shares of the company’s stock worth $2,405,000 after buying an additional 2,234 shares during the period. Finally, Amundi grew its position in shares of McKesson by 33.6% in the 1st quarter. Amundi now owns 623,749 shares of the company’s stock valued at $539,767,000 after buying an additional 156,819 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity at McKesson

In related news, EVP Michele Lau sold 3,550 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at $2,471,259.23. This represents a 52.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the completion of the sale, the chief executive officer owned 5,919 shares of the company’s stock, valued at $4,697,081.64. The trade was a 58.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 28,748 shares of company stock worth $22,262,035 over the last quarter. 0.06% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $875.00 target price on shares of McKesson in a report on Friday, May 8th. Barclays lowered their price target on shares of McKesson from $1,050.00 to $925.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. William Blair initiated coverage on shares of McKesson in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, TD Cowen reduced their price objective on shares of McKesson from $1,012.00 to $989.00 and set a “buy” rating on the stock in a research note on Tuesday, July 21st. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $962.67.

Trending Headlines about McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson continues to benefit from expectations for earnings growth. Its latest reported quarter exceeded EPS estimates, and management’s fiscal 2027 outlook calls for earnings of $43.80–$44.60 per share. McKesson earnings expected to grow
• Neutral Sentiment: McKesson’s chief legal officer is leaving to take the same role at luxury home-furnishings company RH. The move is not necessarily an operating concern, but executive turnover may attract investor attention. RH hires McKesson chief legal officer
• Negative Sentiment: A Zacks preview said McKesson lacks the combination of favorable earnings expectations and estimate-revision momentum that typically signals a likely earnings beat. That caution may have pressured the stock ahead of results, particularly after its strong run toward its 52-week high. McKesson earnings preview
• Negative Sentiment: The latest market recap noted that McKesson declined while the broader market advanced, indicating relative weakness rather than a sector-wide healthcare selloff. Investors appear focused on whether upcoming results can justify the company’s elevated valuation. McKesson stock market recap

McKesson Price Performance

Shares of McKesson stock opened at $867.05 on Friday. The stock’s 50-day moving average is $788.86 and its 200 day moving average is $840.10. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The firm has a market cap of $101.51 billion, a price-to-earnings ratio of 22.54, a PEG ratio of 1.46 and a beta of 0.31.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. During the same period in the previous year, the company posted $10.12 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, sell-side analysts expect that McKesson Corporation will post 44.28 EPS for the current fiscal year.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be paid a $0.94 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. This is an increase from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio (DPR) is presently 9.77%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.